2015
Biological Activity and Molecular Structures of Bis(benzimidazole) and Trithiocyanurate Complexes
KOPEL, Pavel; Dorota WAWRZAK; Vratislav LANGER; Kristyna CIHALOVA; Dagmar CHUDOBOVA et al.Základní údaje
Originální název
Biological Activity and Molecular Structures of Bis(benzimidazole) and Trithiocyanurate Complexes
Autoři
KOPEL, Pavel; Dorota WAWRZAK; Vratislav LANGER; Kristyna CIHALOVA; Dagmar CHUDOBOVA; Radek VESELÝ; Vojtech ADAM a Rene KIZEK
Vydání
Molecules, Basel, MDPI AG, 2015, 1420-3049
Další údaje
Jazyk
angličtina
Typ výsledku
Článek v odborném periodiku
Obor
30211 Orthopaedics
Stát vydavatele
Švýcarsko
Utajení
není předmětem státního či obchodního tajemství
Impakt faktor
Impact factor: 2.465
Označené pro přenos do RIV
Ano
Kód RIV
RIV/00216224:14110/15:00083400
Organizační jednotka
Lékařská fakulta
UT WoS
EID Scopus
Klíčová slova anglicky
coordination compounds; biological activity; trithiocyanuric acid; trimercaptotriazine; single crystal X-ray diffraction; benzimidazole
Štítky
Příznaky
Mezinárodní význam, Recenzováno
Změněno: 5. 2. 2016 10:42, Ing. Mgr. Věra Pospíšilíková
Anotace
V originále
1-(1H-Benzimidazol-2-yl)-N-(1H-benzimidazol-2-ylmethyl)methanamine (abb) and 2-(1H-benzimidazol-2-ylmethylsulfanylmethyl)-1H-benzimidazole (tbb) have been prepared and characterized by elemental analysis. These bis(benzimidazoles) have been further used in combination with trithiocyanuric acid for the preparation of complexes. The crystal and molecular structures of two of them have been solved. Each nickel atom in the structure of trinuclear complex [Ni3(abb)3(H2O)3ttc)](ClO4)3·3H2O·EtOH (1), where ttcH3 = trithiocyanuric acid, is coordinated with three N atoms of abb, the N,S donor set of ttc anion and an oxygen of a water molecule. The crystal of [(tbbH2)(ttcH2)2(ttcH3)(H2O)] (2) is composed of a protonated bis(benzimidazole), two ttcH2 anions, ttcH3 and water. The structure is stabilized by a network of hydrogen bonds. These compounds were primarily synthesized for their potential antimicrobial activity and hence their possible use in the treatment of infections caused by bacteria or yeasts (fungi). The antimicrobial and antifungal activity of the prepared compounds have been evaluated on a wide spectrum of bacterial and yeast strains and clinical specimens isolated from patients with infectious wounds and the best antimicrobial properties were observed in strains after the use of ligand abb and complex 1, when at least 80% growth inhibition was achieved.